Latest news for TrueBlue (NYSE:TBI) Stock

TrueBlue

TrueBlue Inc is a provider of staffing and workforce management solutions. Its reportable segments include PeopleReady offers industrial staffing services. PeopleManagement offers contingent and productivity-based on-site industrial staffing services and PeopleScout offers recruitment process outsourcing, talent advisory services, and managed service provider services. It generates maximum revenue from the PeopleReady segment.

Long Ideas

News

Small Cap

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

ALGN

FITB

Although U.S. stocks closed higher on Wednesday following Fed’s interest-rate decision, there were a few notable insider trades.

$1.5M Bet On This Financial Services Stock? Check Out These 4 Stocks Insiders Are Buying

Earnings

Penny Stocks

Eurozone

Commodities

Global

Intraday Update

AGYS

LIAN

MKFG

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 200 points on Tuesday.

The Dow traded up 0.67% to 33,155.68 while the NASDAQ rose 0.78% to 13,120.31. The S&amp;P 500 also rose, gaining, 0.72% to 4,247.52.

Nasdaq Gains 100 Points; Coca-Cola Earnings Top Expectations

Movers

AGNC

AIRE

AMRX

ARBK

ASPN

ASTI

AWIN

BANC

CALX

CLSK

COIN

COMM

DGHI

FBYD

GDHG

HOUS

HSAI

HSTM

IBRX

INVO

IONQ

IREN

LITM

LMDX

LOGI

MARA

MATX

MDIA

MEDP

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

MSTR

MULN

NKLA

PACW

SFIX

SLNH

SPEC

SPOT

TCRT

TFII

TZOO

VMAR

WASH

XRTX

YOSH

Gainers


	InMed Pharmaceuticals Inc. (NASDAQ: INM) shares climbed 169% to $1.56 after the company announced it selected a lead Alzheimer&#39;s drug candidate following proof-of-concept study data.


Why Asbury Automotive Group Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

TrueBlue Inc

TOBII TECHNOLOGY AB ORD by Tobii Technology AB

Tobii AB

US Treasury 3 Month Bill ETF

Telesis Bio Inc

TrustBIX Inc

BMO Capital analyst Jeffrey Silber maintains TrueBlue (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBI#NYSE">TBI</a>) with a Outperform and lowers the price target from $13 to $12.

Price Target

Analyst Ratings

BMO Capital Maintains Outperform on TrueBlue, Lowers Price Target to $12

WIIM

TrueBlue shares are trading lower after the company reported worse-than-expected Q2 financial results.

TrueBlue (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBI#NYSE">TBI</a>) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.05) by 600 percent. This is a 418.18 percent decrease over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $396.230 million which missed the analyst consensus estimate of $414.472 million by 4.40 percent. This is a 16.69 percent decrease over sales of $475.588 million the same period last year.

Earnings Misses

TrueBlue Q2 2024 Adj. EPS $(0.35) Misses $(0.05) Estimate, Sales $396.230M Miss $414.472M Estimate

BMO Capital analyst Jeffrey Silber maintains TrueBlue (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBI#NYSE">TBI</a>) with a Outperform and maintains $13 price target.

BMO Capital Maintains Outperform on TrueBlue, Maintains $13 Price Target

BMO Capital analyst Jeffrey Silber maintains TrueBlue (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBI#NYSE">TBI</a>) with a Outperform and lowers the price target from $15 to $13.

BMO Capital Maintains Outperform on TrueBlue, Lowers Price Target to $13

Baird analyst Mark Marcon maintains TrueBlue (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBI#NYSE">TBI</a>) with a Outperform and lowers the price target from $14 to $13.

Baird Maintains Outperform on TrueBlue, Lowers Price Target to $13

Offerings

TrueBlue Files For Mixed Shelf Offering Of Up To $200M

TrueBlue (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBI#NYSE">TBI</a>) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.37) by 108.11 percent. This is a 150 percent increase over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $402.853 million which beat the analyst consensus estimate of $400.367 million by 0.62 percent. This is a 13.42 percent decrease over sales of $465.288 million the same period last year.

Earnings Beats

TrueBlue Q1 2024 Adj EPS $0.03 Beats $(0.37) Estimate, Sales $402.853M Beat $400.367M Estimate

<h3>Gainers</h3>
<ul>
<li>ACV Auctions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACVA#NASDAQ">ACVA</a>) shares moved upwards by 22.2% to $17.11 during Wednesday's after-market session. The market value of their outstanding shares is at $2.7 billion. As per the press release, Q4 earnings came out today. </li>
<li>Gaucho Group Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINO#NASDAQ">VINO</a>) stock increased by 6.23% to $0.62. The market value of their outstanding shares is at $4.5 million. </li>
<li>TrueBlue (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBI#NYSE">TBI</a>) stock rose 5.06% to $13.06. The company's market cap stands at $406.6 million. As per the press release, Q4 earnings came out today. </li>
<li>KULR Tech Gr (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KULR#AMEX">KULR</a>) stock increased by 4.99% to $0.15. The market value of their outstanding shares is at $19.4 million. </li>
<li>Sidus Space (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIDU#NASDAQ">SIDU</a>) shares increased by 4.78% to $4.16. The company's market cap stands at $11.6 million. </li>
<li>Hyzon Motors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYZN#NASDAQ">HYZN</a>) stock rose 4.61% to $0.68. The market value of their outstanding shares is at $166.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Ideal Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPWR#NASDAQ">IPWR</a>) shares fell 10.9% to $9.36 during Wednesday's after-market session. The market value of their outstanding shares is at $55.6 million. </li>
<li>Energy Focus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EFOI#NASDAQ">EFOI</a>) stock declined by 9.61% to $2.07. The company's market cap stands at $9.0 million. </li>
<li>Sunrun (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) shares decreased by 8.48% to $14.26. The company's market cap stands at $3.1 billion. The company's, Q4 earnings came out today. </li>
<li>Safe &amp; Green Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) shares fell 5.09% to $0.28. The company's market cap stands at $5.0 million. </li>
<li>Ault Alliance (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AULT#AMEX">AULT</a>) shares decreased by 4.46% to $0.4. The market value of their outstanding shares is at $1.1 million. </li>
<li>Energy Recovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERII#NASDAQ">ERII</a>) shares declined by 3.97% to $15.0. The company's market cap stands at $847.7 million. The company's, Q4 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACVA

AULT

EFOI

ERII

HYZN

IPWR

KULR

SGBX

SIDU

VINO

12 Industrials Stocks Moving In Wednesday's After-Market Session

TrueBlue (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBI#NYSE">TBI</a>) reported its Q4 earnings results on Wednesday, February 21, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
TrueBlue beat estimated earnings by 700.0%, reporting an EPS of $0.08 versus an estimate of $0.01.
Revenue was down $65.52 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.07 which was followed by a 21.67% drop in the share price the next day.
Here's a look at TrueBlue's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.23</td>
<td>0.22</td>
<td>-0.11</td>
<td>0.38</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.16</td>
<td>0.17</td>
<td>-0.06</td>
<td>0.43</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>488.94M</td>
<td>496.11M</td>
<td>465.30M</td>
<td>562.93M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>473.20M</td>
<td>475.59M</td>
<td>465.29M</td>
<td>557.70M</td>
</tr>
</tbody>
</table>

To track all earnings releases for TrueBlue <a href="https://www.benzinga.com/quote/TBI/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TrueBlue: Q4 Earnings Insights

TrueBlue (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBI#NYSE">TBI</a>) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $0.01 by 700 percent. This is a 79.49 percent decrease over earnings of $0.39 per share from the same period last year. The company reported quarterly sales of $492.17 million which beat the analyst consensus estimate of $472.53 million by 4.16 percent. This is a 11.75 percent decrease over sales of $557.70 million the same period last year.

TrueBlue Q4 2023 Adj EPS $0.08 Beats $0.01 Estimate, Sales $492.17M Beat $472.53M Estimate

Creates national staffing platform, drives growth and expands service offerings for clients
TORONTO, Feb. 21, 2024 /CNW/ - Vertical Staffing Resources Inc. ("VSR"), a leading provider of specialized workforce solutions, today announced that it has reached a definitive agreement to acquire PeopleReady's Canadian staffing operations from TrueBlue Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBI#NYSE">TBI</a>). Financial terms of the transaction were not disclosed.
This strategic acquisition marks a major milestone for VSR, enabling it to extend its reach in the staffing industry across Canada and increase value for its clients and employees.&nbsp;
"Significant strategic rationale underpins this acquisition, as it not only broadens our geographical footprint across Canada but also fortifies our diversification into new industry verticals. Importantly, it positions us to effectively meet the growing market need for on-demand labour, aligning with our commitment to address evolving workforce needs," said Anthony Calce, CEO of VSR. "This acquisition will create opportunities for expanded service offerings and we will leverage our technology to streamline processes and enhance the overall experience for all of VSR's clients."

Asset Sales

Vertical Staffing Resources Announces Acquisition Of PeopleReady's Canadian Staffing Operations From TrueBlue Inc.; Financial Terms Of The Transaction Were Not Disclosed

TrueBlue Announces Sale Of PeopleReady's Canadian Staffing Business, Terms Not Disclosed

ALIT

AMSF

ANSS

ATNI

BALY

BELFA

BELFB

BLCO

BRDG

BROS

BRSP

CAKE

CCAP

CCRN

CCSI

CENX

CHDN

CHRD

CNNE

COKE

CSTE

CSTM

DINO

DOCN

ECPG

ESEA

ETSY

EXAS

FIVN

GATO

GKOS

GLBE

GOOD

GRMN

GSHD

ICLR

INSG

IONS

JACK

JOBY

KALU

LANV

LCID

LIVN

LUNG

MATV

MGRC

MTLS

NDSN

NEXA

NGVT

NOVA

NVDA

NVRO

NYMT

OBDC

Earnings Scheduled For February 21, 2024

Sonita Lontoh, Board Member at TrueBlue (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBI#NYSE">TBI</a>), reported a large insider buy on November 7, according to a new SEC filing. 
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0000768899/000076889923000141//Archives/edgar/data/768899/000076889923000141/0000768899-23-000141-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday showed that Lontoh purchased 8,000 shares of TrueBlue. The total transaction amounted to $101,360. 
TrueBlue shares are trading up 0.32% at $12.51 at the time of this writing on Wednesday morning.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Importance of Insider Transactions</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Important Transaction Codes</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000768899">Check Out The Full List Of TrueBlue's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TrueBlue Insider Trades Send a Signal

Robert Kreidler, Director at TrueBlue (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBI#NYSE">TBI</a>), reported a large insider buy on November 2, according to a new SEC filing. 
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0000768899/000076889923000137//Archives/edgar/data/768899/000076889923000137/0000768899-23-000137-index.htm">U.S. Securities and Exchange Commission</a> on Thursday showed that Kreidler purchased 10,000 shares of TrueBlue. The total transaction amounted to $110,700. 
TrueBlue shares are trading up 4.41% at $11.59 at the time of this writing on Thursday morning.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Importance of Insider Transactions</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Transaction Codes To Focus On</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000768899">Check Out The Full List Of TrueBlue's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

110K Reasons To Be Bullish On TrueBlue Stock

Although U.S. stocks closed higher on Wednesday following Fed&rsquo;s interest-rate decision, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#39;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>Fifth Third Bancorp </h3>
<ul>
<li>The Trade: Fifth Third Bancorp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fitb#NASDAQ">FITB</a>) Director C. Bryan Daniels <a href="https://www.benzinga.com/quote/FITB/analyst-ratings"> acquired a total of 64,500 shares </a> an average price of $23.31. To acquire these shares, it cost around $1.5 million.</li>
<li>What&rsquo;s Happening: Fifth Third Bancorp reported better-than-expected earnings for its third quarter.</li>
<li>What Fifth Third Bancorp Does: Fifth Third Bancorp is a diversified financial-services company headquartered in Cincinnati.</li>
</ul>
<h3>Loews </h3>
<ul>
<li>The Trade: Loews Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/l#NYSE">L</a>) Director Jonathan C Locker acquired a total of 15,870 shares at an average price of $63.75. To acquire these shares, it cost around $1.01 million.</li>
<li>What&rsquo;s Happening: Loews reported third-quarter EPS of $1.12, up from a loss of 9 cents a year ago.</li>
<li>What Loews Does: Loews Corp is a holding company that is supported by a variety of businesses. Its largest subsidiary is CNA Financial Corporation, a property and casualty insurance company.</li>
</ul>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
<h3>Align Technology </h3>
<ul>
<li>The Trade: Align Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/algn#NASDAQ">ALGN</a>) President and CEO Joseph M Hogan <a href="https://www.benzinga.com/sec/insider-trades/"> bought a total of 5,319 shares </a> at an average price of $188.00. To acquire these shares, it cost around $1 million.</li>
<li>What&rsquo;s Happening: Align Technology reported worse-than-expected third-quarter financial results and issued guidance.</li>
<li>What Align Technology Does: Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the FDA in 1998, and it has since dominated, controlling over 90% of the market.</li>
</ul>
<h3>TrueBlue </h3>
<ul>
<li>The Trade: TrueBlue, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tbi#NYSE">TBI</a>) Director Robert Kreidler <a href="https://www.benzinga.com/sec/insider-trades/"> bought a total of 10,000 shares </a> at an average price of $11.07. The insider spent around $110,700 to buy those shares.</li>
<li>What&rsquo;s Happening: TrueBlue posted weaker-than-expected results for its third quarter.</li>
<li>What TrueBlue Does: TrueBlue Inc is a provider of staffing and workforce management solutions.</li>
</ul>
&nbsp;
Check This Out: <a href="https://www.benzinga.com/news/earnings/23/11/35555667/fear-continues-to-grip-markets-after-feds-rate-decision"> Fear Continues To Grip Markets After Fed&#39;s Rate Decision </a>

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 200 points on Tuesday.
The Dow traded up 0.67% to 33,155.68 while the NASDAQ rose 0.78% to 13,120.31. The S&amp;P 500 also rose, gaining, 0.72% to 4,247.52.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/10/35387533/never-buy-a-drug-stock-just-for-the-yield-jim-cramer-on-this-big-pharma-company"> &#39;Never Buy A Drug Stock Just For The Yield&#39;: Jim Cramer On This Big Pharma Company</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Utilities shares rose by 2.6% on Tuesday.
In trading on Tuesday, energy shares fell by 1%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
The Coca-Cola Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ko#NYSE">KO</a>) reported better-than-expected third-quarter financial results and raised full-year guidance.
Coca-Cola reported third-quarter FY23 sales growth of 8% year-on-year to $11.95 billion, beating the analyst consensus estimate of $11.44 billion. Adjusted EPS of $0.74 beat the analyst consensus estimate of $0.69.
Coca-Cola raises FY23 organic revenue growth outlook from 8% - 9% to 10% - 11%. The company sees comparable currency neutral EPS growth of 13%-14% (prior 9%-11%).
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
InMed Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inm#NASDAQ">INM</a>) shares shot up 141% to $1.3999 after the company announced it selected a lead Alzheimer&#39;s drug candidate following proof-of-concept study data.
Shares of Agilysys, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agys#NASDAQ">AGYS</a>) got a boost, shooting 26% to $80.37 after reporting second-quarter results.
LianBio (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lian#NASDAQ">LIAN</a>) shares were also up, gaining 136% to $3.2799 after the company announced it entered into an agreement with Bristol Myers Squibb for mavacamten in China and other Asian markets.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
TrueBlue, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tbi#NYSE">TBI</a>) shares dropped 25% to $10.24 as the company posted weaker-than-expected results for its third quarter.
Shares of TransUnion (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tru#NYSE">TRU</a>) were down 24% to $49.29 after the company reported worse-than-expected third-quarter financial results and lowered FY23 guidance.
Markforged Holding Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mkfg#NYSE">MKFG</a>) was down, falling 28% to $0.7726. Markforged sees preliminary third-quarter revenue of $20 million and projects 2023 revenue of $90 million to $95 million, which is below the low end of prior range.
Also Check This Out:<a href="https://www.benzinga.com/news/23/10/35394597/matson-to-rally-around-36-here-are-10-top-analyst-forecasts-for-tuesday"> Matson To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Tuesday</a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded down 1.9% to $83.89 while gold traded down 0.1% at $1,987.00.
Silver traded down 0.4% to $23.115 on Tuesday while copper rose 1.4% to $3.6350.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares closed mostly higher today. The eurozone&rsquo;s STOXX 600 rose 0.44%, London&rsquo;s FTSE 100 rose 0.20% while Spain&rsquo;s IBEX 35 Index fell 0.22% The German DAX rose 0.54% French CAC 40 rose 0.63%, while Italy&rsquo;s FTSE MIB Index rose 0.05%.
The S&amp;P Global/CIPS UK services PMI fell to 49.2 in October from 49.3 in the prior month, while manufacturing PMI climbed to 45.2 from 44.3. Labor productivity in the UK increased by 0.7% on quarter during the second quarter.
The HCOB Eurozone manufacturing PMI declined to 43 in October from 43.4 in the prior month, while services PMI slipped to 47.8 from 48.7. Germany&rsquo;s services PMI fell to 48 in October from 50.3 in the prior month, while manufacturing PMI rose to a five-month high level of 40.7 in October. The HCOB France composite PMI climbed to 45.3 in October from September&rsquo;s reading of 44.1.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mixed on Tuesday, with Japan&rsquo;s Nikkei 225 rising 0.20%, Hong Kong&rsquo;s Hang Seng Index fell 1.05% and China&rsquo;s Shanghai Composite Index gaining 0.78%.
The au Jibun Bank Japan services PMI fell to 51.1 in October from 53.9 in the prior month, while manufacturing PMI came in unchanged at 48.5 in October.
&nbsp;
<h3>Economics</h3>
&nbsp;
The S&amp;P Global manufacturing PMI for the US increased to 50 in October from 49.8 in the prior month and topping market expectations of 49.5.
The S&amp;P Global services PMI rose to 50.9 in October versus 50.1 a month ago.
The manufacturing activity index in the Richmond area fell to a reading of 3 in October versus September&rsquo;s reading of 5.
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/10/35391558/top-5-tech-stocks-which-could-rescue-your-portfolio-this-month"> Top 5 Tech Stocks Which Could Rescue Your Portfolio This Month</a>

<h3>Gainers</h3>
<ul>
<li>InMed Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inm#NASDAQ">INM</a>) shares climbed 169% to $1.56&nbsp;after the company announced it selected a lead Alzheimer&#39;s drug candidate following proof-of-concept study data.</li>
<li>LianBio (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lian#NASDAQ">LIAN</a>) shares climbed 94.3% to $2.7003 after the company entered into agreement with Bristol Myers Squibb for Mavacamten in China and other Asian markets.</li>
<li>Ascent Solar Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asti#NASDAQ">ASTI</a>) climbed 78.1% to $1.7499 after the company received encouragement from the U.S. Department of Energy to submit a full application for federal funding of the Agrivoltaic Product Development Project.</li>
<li>Falcon&#39;s Beyond Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fbyd#NASDAQ">FBYD</a>) gained 36.8% to $17.53.</li>
<li>ImmunityBio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ibrx#NASDAQ">IBRX</a>) jumped 31.4% to $1.88.</li>
<li>AERWINS Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/awin#NASDAQ">AWIN</a>) shares climbed 29.9% to $0.1481 after falling 10% on Monday.</li>
<li>Aspen Aerogels, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aspn#NASDAQ">ASPN</a>) rose 27.8% to $8.52.</li>
<li>SAI.TECH Global Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sai#NYSE">SAI</a>) climbed 26.6% to $1.14.</li>
<li>Mullen Automotive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/muln#NASDAQ">MULN</a>) gained 26.4% to $0.2829.</li>
<li>Digihost Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dghi#NASDAQ">DGHI</a>) rose 26.2% to $1.59.</li>
<li>Travelzoo (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tzoo#NASDAQ">TZOO</a>) surged 24.8% to $6.56 following strong quarterly results.</li>
<li>Yoshiharu Global Co. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yosh#NASDAQ">YOSH</a>) gained 23.6% to $0.5440.</li>
<li>Agilysys, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agys#NASDAQ">AGYS</a>) gained 21.5% to $77.62 after it reported second-quarter results.</li>
<li>Mawson Infrastructure Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/migi#NASDAQ">MIGI</a>) rose 20.2% to $0.8420.</li>
<li>Iris Energy Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iren#NASDAQ">IREN</a>) gained 18.7% to $3.7977. Iris Energy partnered with WEKA to optimize generative AI workloads.</li>
<li>Stitch Fix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sfix#NASDAQ">SFIX</a>) climbed 17.7% to $3.7550.</li>
<li>Nikola Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nkla#NASDAQ">NKLA</a>) jumped 17.3% to $1.1197. Nikola, on Oct 20, said an arbitration panel in New York, New York awarded Nikola approximately $165 million plus interest.</li>
<li>Marathon Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mara#NASDAQ">MARA</a>) rose 17.1% to $10.25 after Bitcoin reached $35,000 for the first time since 2022.</li>
<li>Argo Blockchain plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arbk#NASDAQ">ARBK</a>) shares jumped 17% to $1.2750 after jumping over 12% on Monday.</li>
<li>Medpace Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/medp#NASDAQ">MEDP</a>) gained 16.5% to $265.03 after the company released its third-quarter results.</li>
<li>Hesai Group (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hsai#NASDAQ">HSAI</a>) climbed 16.4% to $11.08.</li>
<li>Amneal Pharmaceuticals, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amrx#NYSE">AMRX</a>) rose 15.7% to $3.8881. Amneal Pharmaceuticals sees preliminary third-quarter net revenue of $610 million to $620 million.</li>
<li>Diversified Healthcare Trust (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dhc#NASDAQ">DHC</a>) surged 15.1% to $1.98 as the company issued monthly SHOP performance update.</li>
<li>MicroStrategy Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstr#NASDAQ">MSTR</a>) gained 15% to $433.80 as Bitcoin continues to rise on spot ETF optimism.</li>
<li>CleanSpark, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clsk#NASDAQ">CLSK</a>) rose 14.2% to $4.86 after Bitcoin reached $35,000 for the first time since 2022..</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kc#NASDAQ">KC</a>) gained 13.6% to $5.05.</li>
<li>Anywhere Real Estate Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hous#NYSE">HOUS</a>) climbed 13.6% to $4.68 following quarterly results.</li>
<li>Coinbase Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>) gained 13.4% to $87.53 after Bitcoin reached $35,000 for the first time since 2022.</li>
<li>Vision Marine Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vmar#NASDAQ">VMAR</a>) gained 12.1% to $2.1850.</li>
<li>Logitech International S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/logi#NASDAQ">LOGI</a>) shares rose 11.7% to $76.43 as the company posted upbeat second-quarter results and raised its FY24 revenue guidance outlook.</li>
<li>Soluna Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slnh#NASDAQ">SLNH</a>) gained 11.5% to $3.38 after gaining 13% on Monday. Soluna achieved record low power costs paving the way for AI computing at Project Dorothy.</li>
<li>Crane Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cr#NYSE">CR</a>) jumped 11.2% to $91.90 following strong quarterly results.</li>
<li>Snow Lake Resources Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/litm#NASDAQ">LITM</a>) rose 11.1% to $1.03.</li>
<li>Matson, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/matx#NYSE">MATX</a>) gained 10.9% to $94.68 after reporting preliminary third-quarter results.</li>
<li>Spotify Technology S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spot#NYSE">SPOT</a>) rose 10.7% to $171.18 after the company reported third-quarter results. Premium revenue grew 10% year over year and total MAUs rose 26%.</li>
<li>HealthStream, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hstm#NASDAQ">HSTM</a>) gained 10.7% to $24.28 following third-quarter results.</li>
<li>Armstrong World Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/awi#NYSE">AWI</a>) climbed 10% to $75.99 as the company posted upbeat third-quarter results and raised FY23 earnings guidance.</li>
<li>Verizon Communications Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vz#NYSE">VZ</a>) gained 8.7% to $34.11 after the company reported better-than-expected third-quarter financial results and issued guidance.</li>
<li>CommScope Holding Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/comm#NASDAQ">COMM</a>) gained 8.5% to $2.4314. CommScope is expected to release its third quarter 2023 financial results on Nov. 9.</li>
<li>Cleveland-Cliffs Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/clf#NYSE">CLF</a>) surged 8% to $15.52 after the company reported strong quarterly results.</li>
<li>General Electric Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ge#NYSE">GE</a>) gained 7.3% to $114.61 after the company reported third-quarter financial results and issued guidance.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>reAlpha Tech Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aire#NASDAQ">AIRE</a>) shares dipped 70.7% to $119.00. reAlpha announced effectiveness of registration statement for proposed direct listing of its common stock on Nasdaq.</li>
<li>LumiraDx Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lmdx#NASDAQ">LMDX</a>) shares fell 42% to $0.1596. LumiraDx shares jumped 216% on Monday after the company announced a strategic collaboration with AstraZeneca and Everton in the Community to set up England&#39;s first community-based heart and lung screening hub.</li>
<li>INVO Bioscience, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/invo#NASDAQ">INVO</a>) shares fell 34% to $1.40 after jumping over 292% on Monday. The company announced it will acquire NAYA Biosciences in an all-stock transaction.</li>
<li>Markforged Holding Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mkfg#NASDAQ">MKFG</a>) shares dipped 27.8% to $0.7801. Markforged sees preliminary third-quarter revenue of $20 million and projects 2023 revenue of $90 million to $95 million, which is below the low end of prior range.</li>
<li>Spectaire Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spec#NASDAQ">SPEC</a>) fell 25.2% to $2.25.</li>
<li>TransUnion (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tru#NYSE">TRU</a>) fell 24.6% to $48.88 after the company reported worse-than-expected third-quarter financial results and lowered FY23 guidance.</li>
<li>Calix, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/calx#NYSE">CALX</a>) dipped 23.3% to $32.67 after the company reported third-quarter financial results and issued guidance.</li>
<li>TrueBlue, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tbi#NYSE">TBI</a>) shares declined 20.6% to $10.85 as the company posted weaker-than-expected results for its third quarter.</li>
<li>The Aaron&#39;s Company, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aan#NYSE">AAN</a>) dropped 19.8% to $7.13 as the company reported a third-quarter FY23 sales decline of 11.4% year-on-year to $525.68 million, missing the analyst consensus estimate of $536.10 million..</li>
<li>MediaCo Holding Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdia#NASDAQ">MDIA</a>) fell 18.3% to $0.63.</li>
<li>ENGlobal Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eng#NASDAQ">ENG</a>) declined 16.4% to $0.2601.</li>
<li>XORTX Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xrtx#NASDAQ">XRTX</a>) shares fell 14.2% to $0.3610 after dipping 34% on Monday.</li>
<li>Xerox Holdings Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xrx#NYSE">XRX</a>) declined 8.8% to $12.29 as the company reported a third-quarter FY23 sales decline of 5.7% year-on-year to $1.65 billion, missing the consensus of $1.71 billion.</li>
<li>Washington Trust Bancorp, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wash#NASDAQ">WASH</a>) declined 8.7% to $22.59 after the company reported a year-over-year decrease in EPS for the third quarter.</li>
<li>PacWest Bancorp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pacw#NASDAQ">PACW</a>) declined 8.5% to $6.68 following weak quarterly results.</li>
<li>Hexcel Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hxl#NYSE">HXL</a>) fell 8.2% to $59.60 after reporting weaker-than-expected third-quarter financial results.</li>
<li>TFI International Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tfii#NYSE">TFII</a>) fell 8% to $107.36 after the company reported worse-than-expected earnings results.</li>
<li>IonQ, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ionq#NASDAQ">IONQ</a>) fell 7.8% to $11.65. IonQ said Dr. Chris Monroe, Chief Science Officer, will be leaving the company.</li>
<li>Alaunos Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcrt#NASDAQ">TCRT</a>) fell 7.2% to $0.1022 after climbing around 6% on Monday.</li>
<li>Golden Heaven Group Holdings Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gdhg#NASDAQ">GDHG</a>) declined 7.2% to $12.60.</li>
<li>Banc of California, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/banc#NYSE">BANC</a>) fell 6.6% to $10.52 after the company reported worse-than-expected third-quarter revenue results.</li>
<li>Asbury Automotive Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/abg#NYSE">ABG</a>) declined 6.5% to $ 186.15 following weak quarterly results.</li>
<li>Barclays PLC (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bcs#NYSE">BCS</a>) shares fell 6.4% to $6.57 after reporting results for the third quarter.</li>
<li>AGNC Investment Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agnc#NASDAQ">AGNC</a>) shares fell 6% to $7.63 as the company reported preliminary estimates for the third quarter.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/10/35387533/never-buy-a-drug-stock-just-for-the-yield-jim-cramer-on-this-big-pharma-company"> &#39;Never Buy A Drug Stock Just For The Yield&#39;: Jim Cramer On This Big Pharma Company </a>

Why Asbury Automotive Group Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>Bridger Aerospace Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAER#NASDAQ">BAER</a>) stock rose 20.7% to $4.9 during Tuesday's regular session. Bridger Aerospace Gr's stock is trading at a volume of 584.3K shares as of 13:31 EST. This is 1423.6% of its average full-day volume over the last 100 days. The company's market cap stands at $219.4 million. </li>
<li>Crane (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) stock increased by 13.62% to $93.94. Trading volume for this security as of 13:31 EST is 537.5K, which is 272.5% of its average full-day volume over the last 100 days. The company's market cap stands at $5.3 billion. The company's, Q3 earnings came out yesterday. </li>
<li>ESGL Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESGL#NASDAQ">ESGL</a>) stock rose 12.35% to $0.66. The market value of their outstanding shares is at $8.3 million. </li>
<li>Applied UV (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUVIP#NASDAQ">AUVIP</a>) stock increased by 11.41% to $2.93. </li>
<li>AERWINS Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AWIN#NASDAQ">AWIN</a>) shares increased by 11.14% to $0.13. As of 13:31 EST, this security is trading at a volume of 32.8 million shares, making up 414.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $7.9 million. </li>
<li>Nikola (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKLA#NASDAQ">NKLA</a>) stock increased by 11.04% to $1.06. Trading volume for this security as of 13:31 EST is 63.8 million, which is 81.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.0 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Markforged Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKFG#NYSE">MKFG</a>) stock decreased by 28.7% to $0.77 during Tuesday's regular session. Trading volume for Markforged Holding's stock is 4.6 million as of 13:31 EST. This is 308.5% of its average full-day volume over the last 100 days. The company's market cap stands at $151.8 million. </li>
<li>TransUnion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRU#NYSE">TRU</a>) stock decreased by 25.49% to $48.32. Trading volume for this security as of 13:31 EST is 10.1 million, which is 824.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $9.3 billion. As per the news, the Q3 earnings report came out today. </li>
<li>TrueBlue (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBI#NYSE">TBI</a>) shares decreased by 24.16% to $10.36. Trading volume for TrueBlue's stock is 845.7K as of 13:31 EST. This is 368.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $321.2 million. As per the press release, Q3 earnings came out yesterday. </li>
<li>Erayak Power Solution Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAYA#NASDAQ">RAYA</a>) shares decreased by 12.51% to $0.72. The market value of their outstanding shares is at $8.9 million. </li>
<li>Addentax Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXG#NASDAQ">ATXG</a>) stock fell 11.37% to $1.37. Trading volume for Addentax Group's stock is 96.8K as of 13:31 EST. This is 77.5% of its average full-day volume over the last 100 days. The company's market cap stands at $5.9 million. </li>
<li>ATIF Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATIF#NASDAQ">ATIF</a>) shares declined by 10.79% to $1.2. The company's market cap stands at $11.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATIF

ATXG

AUVIP

BAER

ESGL

RAYA

12 Industrials Stocks Moving In Tuesday's Intraday Session

Palm Valley Capital Fund Q2 2024 Commentary

TrueBlue GAAP EPS of -$3.45 misses by $3.39, revenue of $396M misses by $18.47M

The latest announcement is out from Trueblue (TBI). Our latest Investor Roadshow Presentation, now available on our website and attached to this re...

Trueblue Investor Roadshow Presentation Insights Unveiled

The latest update is out from Trueblue (TBI). TrueBlue, Inc. has announced the promotion of Jason Embick to Senior Vice President and Chief Account...

TrueBlue Elevates Jason Embick to Senior VP and CAO

TrueBlue, Inc. 2024 Q2 - Results - Earnings Call Presentation

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
TrueBlue (NYSE:<a href="https://investorplace.com/stock-quotes/tbi-stock-quote/">TBI</a>) just reported results for the second quarter of 2024.<ul><li>TrueBlue reported earnings per share of -35 cents. This was below the analyst estimate for EPS of -5 cents.</li><li>The company reported revenue of $396.23 million.</li><li>This was 4.40% worse than the analyst estimate for revenue of $414.47 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/tbi-stock-earnings-trueblue-for-q2-of-2024/">TBI Stock Earnings: TrueBlue Misses EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

TBI Stock Earnings: TrueBlue Misses EPS, Misses Revenue for Q2 2024

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

TrueBlue

News

Latest news for TrueBlue (NYSE:TBI) Stock

People Also Watch